Communiqués Terumo Corporation OTC Markets

Actions

TRUMY

US88156J1051

Marché Fermé - OTC Markets Autres places de cotation 21:49:57 24/06/2024			Varia. 5j.	Varia. 1 janv.
16,16 ^USD	+0,81%		-1,52%	-0,92%

11/06	Le Nikkei japonais progresse grâce aux actions américaines et aux actions de poids lourds du secteur des semi-conducteurs	RE
28/05	Terumo Cardiovascular annonce l'autorisation 510(K) du système de surveillance CDI Oneview ? pour le système de surveillance CDI Oneview ?	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Terumo Cardiovascular Announces 510(K) Clearance for the CDI OneView Monitoring System	29/05	AQ
Terumo : NICE PUBLISHES A GUIDANCE SUPPORTING THE USE OF SELECTIVE INTERNAL RADIATION THERAPY FOR NEUROENDOCRINE TUMORS WITH LIVER METASTATIS	17/05	PU
Terumo : Q&A Session at the Financial Results Briefing for the Fiscal Year Ended March 31, 2024	16/05	PU
Terumo : Financial Results for the Fiscal Year Ended March 31, 2024 (FY2023)(with note)	15/05	PU
Terumo : The Future of Terumo "Our vision and the path to it"	14/05	PU
Terumo : Financial Results for the Fiscal Year Ended March 31, 2024	14/05	PU
Terumo : Appoints the Candidates for Directors	14/05	PU
IceCure Medical CEO Issues Letter to Shareholders and Reports Increase in Sales in Preliminary Unaudited 2023 Results	11/01	AQ
Terumo : Blood and Cell Technologies takes part in Connecting the DotsA new film series showcasing the pivotal role of medical technologies to improve healthcare	06/12	PU
Terumo : expands global presence with new subsidiary in South-Africa	30/11	PU
MicroVention Celebrates 10-Year Anniversary and Legacy of SOFIA™ Aspiration Catheters; More than 500,000 Procedures Performed Worldwide Across 170 Countries	16/11	BU
Terumo : India Introduces Insulin Syringe for Patients Requiring Daily Insulin Injections to Manage Diabetes	16/11	PU
Terumo : Olympus and Terumo Announce Change in Form of Contract	31/10/23	PU
Terumo : Blood and Cell Technologies launches study with BioCentriq® to generate public CAR-T cell data using Terumo BCT’s CGT manufacturing platformsData will detail how the Terumo BCT’s Quantum Flex® Cell Expansion System and Finia® Fill and Finish System with BioCentriq’s LEAP™ Advanced Therapy Platform can help accelerate delivery of CAR-T therapies to patients	06/10/23	PU
ANGIO-SEAL™ VIP & FEMOSEAL™ VASCULAR CLOSURE DEVICES SECURED CE CERTIFICATE UNDER THE NEW MEDICAL DEVICE REGULATIONTerumo (TSE: 4543) is proud to announce that both of our Vascular Closure Devices, Angio-Seal™ VIP & Femoseal™, received the EU MDR certifications.	06/10/23	PU
Terumo : to Cease Distributing Dexcom Continuous Glucose Monitoring Systems as Dexcom Moves to a Direct Distribution Model in Japan	02/10/23	PU
MicroVention Enters Transradial Access Therapy; Receives FDA Clearance of SOFIA™ EX 5F 115cm Intracranial Support Catheter	21/09/23	BU
Terumo : Financial Results for the First Quarter of Fiscal Year Ending March 31, 2024 (FY2023)(with note)	10/08/23	PU
Terumo : IFRS Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2024	09/08/23	PU
Terumo : Financial Results for the First Quarter of Fiscal Year Ending March 31, 2024 (FY2023)	09/08/23	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Terumo Corporation OTC Markets

Actions

TRUMY

US88156J1051

Communiqués

Filtres